Schedule 13G ownership disclosure
Cytek Biosciences Inc
Security class unavailable · CUSIP: 23285D109
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,657,030
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-001733
- Form type
- SC 13G
- Filer
- Cytek Biosciences, Inc.
- CIK
- CIK 1831915
- Filed
- Feb 14, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership